| GO ID | GO:0001077 |
| Ontology | MF |
| GO Term | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding |
| Definition | Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
MEIS1 |
Meis homeobox 1 |
4211 |
O00470 |
chr2: 66,433,452-66,573,869 |
|
NR5A2 |
nuclear receptor subfamily 5 group A member 2 |
2494 |
O00482 |
chr1: 200,027,602-200,177,424 |
|
NFIB |
nuclear factor I/B |
4781 |
O00712 |
chr9: 14,081,843-14,398,983 |
|
PLSCR1 |
phospholipid scramblase 1 |
5359 |
O15162 |
chr3: 146,515,180-146,544,864 |
|
SOX12 |
SRY-box 12 |
6666 |
O15370 |
chr20: 325,595-330,224 |
|
KLF4 |
Kruppel-like factor 4 (gut) |
9314 |
O43474 |
chr9: 107,484,852-107,490,482 |
|
TCF21 |
transcription factor 21 |
6943 |
O43680 |
chr6: 133,889,138-133,895,553 |
|
MITF |
microphthalmia-associated transcription factor |
4286 |
O75030 |
chr3: 69,739,435-69,968,337 |
|
NFAT5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
10725 |
O94916 |
chr16: 69,565,094-69,704,666 |
|
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
2353 |
P01100 |
chr14: 75,278,774-75,282,230 |
|
MYC |
v-myc avian myelocytomatosis viral oncogene homolog |
4609 |
P01106 |
chr8: 127,735,434-127,741,434 |
|
ESR1 |
estrogen receptor 1 |
2099 |
P03372 |
chr6: 151,656,691-152,129,619 |
|
NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
2908 |
P04150 |
chr5: 143,277,931-143,435,512 |
|
JUN |
jun proto-oncogene |
3725 |
P05412 |
chr1: 58,780,788-58,784,327 |
|
PGR |
progesterone receptor |
5241 |
P06401 |
chr11: 101,029,624-101,130,524 |
|
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
4782 |
P08651 |
chr19: 3,314,403-3,469,217 |
|
GLI2 |
GLI family zinc finger 2 |
2736 |
P10070 |
chr2: 120,735,623-120,992,653 |
|
GLI3 |
GLI family zinc finger 3 |
2737 |
P10071 |
chr7: 41,960,950-42,237,870 |
|
MYBL1 |
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
4603 |
P10243 |
chr8: 66,562,175-66,614,247 |
|
MYBL2 |
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
4605 |
P10244 |
chr20: 43,667,019-43,716,496 |
|
AR |
androgen receptor |
367 |
P10275 |
chrX: 67,544,032-67,730,619 |
|
IRF1 |
interferon regulatory factor 1 |
3659 |
P10914 |
chr5: 132,481,609-132,490,798 |
|
EGR2 |
early growth response 2 |
1959 |
P11161 |
chr10: 62,811,996-62,919,900 |
|
ESRRA |
estrogen-related receptor alpha |
2101 |
P11474 |
chr11: 64,305,572-64,316,743 |
|
FOSL1 |
FOS-like antigen 1 |
8061 |
P15407 |
chr11: 65,892,049-65,900,573 |
|
TCF4 |
transcription factor 4 |
6925 |
P15884 |
chr18: 55,222,331-55,664,787 |
|
CREB1 |
cAMP responsive element binding protein 1 |
1385 |
P16220 |
chr2: 207,529,737-207,603,431 |
|
JUNB |
jun B proto-oncogene |
3726 |
P17275 |
chr19: 12,791,496-12,793,315 |
|
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
1051 |
P17676 |
chr20: 50,190,734-50,192,689 |
|
EGR1 |
early growth response 1 |
1958 |
P18146 |
chr5: 138,465,490-138,469,315 |
|
ATF4 |
activating transcription factor 4 |
468 |
P18848 |
chr22: 39,519,695-39,522,685 |
|
ELK1 |
ELK1, member of ETS oncogene family |
2002 |
P19419 |
chrX: 47,635,521-47,650,604 |
|
WT1 |
Wilms tumor 1 |
7490 |
P19544 |
chr11: 32,387,775-32,435,630 |
|
HNF1A |
HNF1 homeobox A |
6927 |
P20823 |
chr12: 120,978,543-121,002,512 |
|
NR4A1 |
nuclear receptor subfamily 4 group A member 1 |
3164 |
P22736 |
chr12: 52,022,832-52,059,507 |
|
MZF1 |
myeloid zinc finger 1 |
7593 |
P28698 |
chr19: 58,561,931-58,573,575 |
|
HOXA10 |
homeobox A10 |
3206 |
P31260 |
chr7: 27,170,591-27,180,261 |
|
OTX2 |
orthodenticle homeobox 2 |
5015 |
P32243 |
chr14: 56,799,905-56,810,479 |
|
DDIT3 |
DNA damage inducible transcript 3 |
1649 |
P35638 |
chr12: 57,516,588-57,520,517 |
|
SREBF1 |
sterol regulatory element binding transcription factor 1 |
6720 |
P36956 |
chr17: 17,810,399-17,837,002 |
|
PBX1 |
pre-B-cell leukemia homeobox 1 |
5087 |
P40424 |
chr1: 164,555,584-164,899,296 |
|
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
6774 |
P40763 |
chr17: 42,313,324-42,388,568 |
|
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
2004 |
P41970 |
chr12: 96,194,382-96,269,835 |
|
NR4A2 |
nuclear receptor subfamily 4 group A member 2 |
4929 |
P43354 |
chr2: 156,324,432-156,342,348 |
|
SOX9 |
SRY-box 9 |
6662 |
P48436 |
chr17: 72,121,020-72,126,420 |
|
CEBPD |
CCAAT/enhancer binding protein (C/EBP), delta |
1052 |
P49716 |
chr8: 47,736,909-47,739,086 |
|
MEOX1 |
mesenchyme homeobox 1 |
4222 |
P50221 |
chr17: 43,640,388-43,661,954 |
|
ETV1 |
ets variant 1 |
2115 |
P50549 |
chr7: 13,891,228-13,991,425 |
|
STAT5B |
signal transducer and activator of transcription 5B |
6777 |
P51692 |
chr17: 42,199,168-42,276,707 |
|
HMGA2 |
high mobility group AT-hook 2 |
8091 |
P52926 |
chr12: 65,824,131-65,966,295 |
|
FOSB |
FBJ murine osteosarcoma viral oncogene homolog B |
2354 |
P53539 |
chr19: 45,467,995-45,475,179 |
|
CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
1054 |
P53567 |
chr19: 33,373,330-33,382,686 |
|
NR1H2 |
nuclear receptor subfamily 1 group H member 2 |
7376 |
P55055 |
chr19: 50,329,653-50,382,982 |
|
DLX5 |
distal-less homeobox 5 |
1749 |
P56178 |
chr7: 97,020,392-97,025,097 |
|
FOXL2 |
forkhead box L2 |
668 |
P58012 |
chr3: 138,944,224-138,947,140 |
|
YBX1 |
Y-box binding protein 1 |
4904 |
P67809 |
chr1: 42,682,427-42,702,349 |
|
ELF3 |
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
1999 |
P78545 |
chr1: 202,007,945-202,017,188 |
|
TFAM |
transcription factor A, mitochondrial |
7019 |
Q00059 |
chr10: 58,385,022-58,399,221 |
|
MEF2A |
myocyte enhancer factor 2A |
4205 |
Q02078 |
chr15: 99,565,417-99,716,466 |
|
CEBPZ |
CCAAT/enhancer binding protein (C/EBP), zeta |
10153 |
Q03701 |
chr2: 37,201,612-37,231,713 |
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A |
5970 |
Q04206 |
chr11: 65,653,596-65,663,094 |
|
MEF2C |
myocyte enhancer factor 2C |
4208 |
Q06413 |
chr5: 88,717,117-88,904,257 |
|
GABPA |
GA binding protein transcription factor alpha subunit |
2551 |
Q06546 |
chr21: 25,734,570-25,772,460 |
|
PAX8 |
paired box 8 |
7849 |
Q06710 |
chr2: 113,215,997-113,278,950 |
|
SOX4 |
SRY-box 4 |
6659 |
Q06945 |
chr6: 21,592,768-21,598,619 |
|
PPARA |
peroxisome proliferator-activated receptor alpha |
5465 |
Q07869 |
chr22: 46,150,521-46,243,756 |
|
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
4773 |
Q13469 |
chr20: 51,386,957-51,562,831 |
|
SMAD4 |
SMAD family member 4 |
4089 |
Q13485 |
chr18: 51,028,394-51,085,045 |
|
RUNX2 |
runt-related transcription factor 2 |
860 |
Q13950 |
chr6: 45,328,157-45,664,349 |
|
NFYC |
nuclear transcription factor Y subunit gamma |
4802 |
Q13952 |
chr1: 40,691,648-40,771,603 |
|
MEF2D |
myocyte enhancer factor 2D |
4209 |
Q14814 |
chr1: 156,463,727-156,500,828 |
|
MTF1 |
metal-regulatory transcription factor 1 |
4520 |
Q14872 |
chr1: 37,809,567-37,859,620 |
|
SMAD2 |
SMAD family member 2 |
4087 |
Q15796 |
chr18: 47,808,957-47,931,146 |
|
SMAD1 |
SMAD family member 1 |
4086 |
Q15797 |
chr4: 145,481,194-145,558,079 |
|
ZIC1 |
Zic family member 1 |
7545 |
Q15915 |
chr3: 147,393,422-147,510,293 |
|
HLF |
hepatic leukemia factor |
3131 |
Q16534 |
chr17: 55,265,012-55,325,065 |
|
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
3091 |
Q16665 |
chr14: 61,695,513-61,748,259 |
|
PLAG1 |
PLAG1 zinc finger |
5324 |
Q6DJT9 |
chr8: 56,160,904-56,211,324 |
|
AKNA |
AT-hook transcription factor |
80709 |
Q7Z591 |
chr9: 114,334,156-114,394,405 |
|
CTCFL |
CCCTC-binding factor (zinc finger protein)-like |
140690 |
Q8NI51 |
chr20: 57,495,966-57,525,652 |
|
NR4A3 |
nuclear receptor subfamily 4 group A member 3 |
8013 |
Q92570 |
chr9: 99,821,855-99,866,891 |
|
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
90993 |
Q96BA8 |
chr11: 46,277,661-46,321,422 |
|
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
9971 |
Q96RI1 |
chr12: 100,473,708-100,564,413 |
|
TCF12 |
transcription factor 12 |
6938 |
Q99081 |
chr15: 56,918,623-57,299,281 |
|
MEIS3 |
Meis homeobox 3 |
56917 |
Q99687 |
chr19: 47,403,124-47,419,523 |
|
PITX2 |
paired-like homeodomain 2 |
5308 |
Q99697 |
chr4: 110,617,423-110,642,123 |
|
EPAS1 |
endothelial PAS domain protein 1 |
2034 |
Q99814 |
chr2: 46,293,667-46,386,703 |
|
NUCKS1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
64710 |
Q9H1E3 |
chr1: 205,712,819-205,750,276 |
|
EBF2 |
early B-cell factor 2 |
64641 |
Q9HAK2 |
chr8: 25,841,730-26,045,397 |
|
PATZ1 |
POZ (BTB) and AT hook containing zinc finger 1 |
23598 |
Q9HBE1 |
chr22: 31,325,804-31,346,232 |
|
HEYL |
hes-related family bHLH transcription factor with YRPW motif-like |
26508 |
Q9NQ87 |
chr1: 39,624,153-39,639,945 |
|
EHF |
ets homologous factor |
26298 |
Q9NZC4 |
chr11: 34,621,093-34,661,057 |
|
GRHL1 |
grainyhead-like transcription factor 1 |
29841 |
Q9NZI5 |
chr2: 9,951,693-10,002,277 |
|
ZNF639 |
zinc finger protein 639 |
51193 |
Q9UID6 |
chr3: 179,322,991-179,338,583 |
|
KLF15 |
Kruppel-like factor 15 |
28999 |
Q9UIH9 |
chr3: 126,342,635-126,357,442 |
|
KLF13 |
Kruppel-like factor 13 |
51621 |
Q9Y2Y9 |
chr15: 31,326,855-31,435,665 |
|
MAFB |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
9935 |
Q9Y5Q3 |
chr20: 40,685,848-40,689,240 |
|
CAMTA1 |
calmodulin binding transcription activator 1 |
23261 |
Q9Y6Y1 |
chr1: 6,785,324-7,769,706 |